FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Medical Devices

Abbott IDE OKd for Coronary Artery Blockages Trial

FDA approves an Abbott IDE for a clinical trial to evaluate its investigational coronary intravascular lithotripsy system and its use for treating sev...

latest-news-card-1
FDA General

New FDA Building Completed as DOGE Cuts 27 Others

The government completes a construction project for a new 11,000 square feet FDA annex building in San Juan District as the Trump Administration eyes ...

latest-news-card-1
Human Drugs

No Panel Review for Tonix Pharma Fibromyalgia NDA

FDA passes on holding an advisory committee meeting to review a Tonix Pharmaceuticals NDA for TNX-102 SL (cyclobenzaprine HCl sublingual tablets) for ...

latest-news-card-1
Human Drugs

Fast Track for Secretome Heart Failure Drug

FDA awards Secretome Therapeutics a fast track designation for STM-01, the companys neonatal cardiac progenitor cell therapy for treating certain pat...

latest-news-card-1
Medical Devices

FDA Clears Tenon Medical Expanded Use

FDA clears a Tenon Medical 510(k) for an expanded indication for the Catamaran SI Joint Fusion System for use in augmenting thoracolumbar fusion.

Medical Devices

Bard Recalls Rotarex Atherectomy Device Instructions

Bard Peripheral Vascular updates the instructions for use (Class 1 recall) for its Rotarex Atherectomy Systems after receiving reports about the helix...

latest-news-card-1
Human Drugs

FDA Again Delays Non-Rx Drug Final Rule

FDA delays again a final rule entitled Nonprescription Drug Product With an Additional Condition for Nonprescription Use (ACNU) to allow the Trump Adm...

latest-news-card-1
Human Drugs

Liver Cancer Combo Gets 2nd Complete Response Letter

HLB and Chinas Antengene say FDA has issued a second complete response letter on rivoceranib and its use in combination with camrelizumab for treating...

FDA General

Former FDA Deputy Bumpus Lands at Recursion

Former FDA principal deputy commissioner and second-in-command Namandj Bumpus joins the board of Recursion, a Tech/Bio company that looks to decode bi...

Biologics

Tremfya Approved for Crohns Disease

FDA approves a Johnson & Johnson supplemental BLA for Tremfya (guselkumab) and its use in treating adults with moderately to severely active Crohns di...